FINAFTA
MULTIORAL- benzocaine spray
Efficient Laboratories Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Warnings: Do not exceed recommended dosage
Methemoglobinemia warning: Use of this product may cause mthemoglobinemia, a serious condition that must be treated promptyly because it reduces the amount of oxygen carried in the blood. This can occur even if you have used this product before. Stop use and seek immediate medical attention if you or a child in your care develops:
Allegry alert
do not use this product if you have a history of allergy to local anesthetics such as prcaine, butacaine, bezocaine, or other "caine" anesthetics.
Do not use
Consult a doctor promptly if:
sore mouth symptoms do not improve in 7 days, or if irritation, pain, or redness persists or worsens. If sore throat is sever, persists for more than 2 days, is accompanied or followed by fever, headache, rash, swelling, nausea, or vomiting.
Keep Out of reach of children. In case of accidental overdose, get medical help or contact a Poison
Control Center right away.
DIRECTIONS:
For children over 12 years of age and Adults
• Apply Finafta® MultiOral Spray up to 4 times daily to affected areas of the mouth, gums or mucus membranes (mouth and throat).
• Close bottle tightly after each use.
USES
For the temporary relief of occasional minor irritation, pain, sore mouth, pain associated with canker sores or pain due to minor irritation of the mouth and gums cause by dentures or othodontic applicances.
FINAFTA
MULTIORAL
benzocaine spray |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - Efficient Laboratories Inc. (969044932) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
Dextrum Laboratories Inc. | 007392322 | manufacture(58593-782) |